Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and Methotrexate in Early Rheumatoid Arthritis
NCT00195494Phase 4Completed
- Sponsor
- Pfizer
- Start
- Nov 2004
- Primary completion
- Mar 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etanercept in rheumatoid arthritis (RA) (4 arms), sponsored by Pfizer. Primary endpoints: Number of Participants Achieving Remission As Measured by a Disease Activity Score for 28 Joints (DAS 28) < 2.6 at 12 months and Year 1 Participants Having an Annualized Modified Total Sharp Score (mTSS) < 0.5. Started Nov 2004; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00195494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195494.